Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul;295(1):F128-36.
doi: 10.1152/ajprenal.00577.2007. Epub 2008 Apr 23.

Sevoflurane protects against renal ischemia and reperfusion injury in mice via the transforming growth factor-beta1 pathway

Affiliations

Sevoflurane protects against renal ischemia and reperfusion injury in mice via the transforming growth factor-beta1 pathway

H Thomas Lee et al. Am J Physiol Renal Physiol. 2008 Jul.

Abstract

We previously demonstrated that several clinically utilized volatile anesthetics including sevoflurane protected against renal ischemia-reperfusion (IR) injury by reducing necrosis and inflammation in vivo. We also demonstrated that volatile anesthetics produced direct anti-necrotic and anti-inflammatory effects in cultured renal tubules via mechanisms involving the externalization of phosphatidylserine and subsequent release of transforming growth factor (TGF)-beta1. In this study, we tested the hypothesis that volatile anesthetic-mediated renal protection requires TGF-beta1 and SMAD3 signaling in vivo. We subjected TGF-beta1+/+, TGF-beta1+/-, SMAD3+/+, or SMAD3-/- mice to renal IR under anesthesia with pentobarbital sodium or with sevoflurane. Although TGF-beta1+/+ and SMAD3+/+ mice were significantly protected against renal IR injury under sevoflurane anesthesia with reduced necrosis and inflammation, TGF-beta1+/- mice and SMAD3-/- mice were not protected against renal IR with sevoflurane. Furthermore, a neutralizing TGF-beta1 antibody blocked renal protection with sevoflurane in TGF-beta1+/+ mice. Sevoflurane caused nuclear translocation of SMAD3 and reduced the TNF-alpha-induced nuclear translocation of NF-kappaB in primary cultures of proximal tubules from TGF-beta1+/+ but not in TGF-beta1+/- mice. Finally, sevoflurane protected against necrosis induced with hydrogen peroxide in primary cultures of proximal tubules from TGF-beta1+/+ mice or SMAD3+/+ mice but not in proximal tubules from TGF-beta1+/- or SMAD3-/- mice. Therefore, we demonstrate in this study that sevoflurane-mediated renal protection in vivo requires the TGF-beta1-->SMAD3 signaling pathway.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
A: representative gel images of semiquantitative RT-PCR results of transforming growth factor (TGF)-β1 and GAPDH mRNAs from TGF-β1+/+ and TGF-β1+/− mouse renal cortices. Representative images from 3 experiments are shown. B: densitometric quantifications of relative band intensities from RT-PCR reactions (n = 3). TGF-β1 mRNA band intensity was first normalized against GAPDH band intensity. *P < 0.001 vs. TGF-β1+/+ mice. Data presented as means ± SE.
Fig. 2.
Fig. 2.
Mouse plasma TGF-β1 concentration (in pg/ml) in TGF-β1+/+ mice (n = 10), TGF-β1+/− mice (n = 10), and TGF-β1+/+ mice injected with TGF-β1 neutralizing antibody (n = 4). Total plasma TGF-β1 concentrations were determined with ELISA. *P < 0.01 vs. TGF-β1+/+ mice. Data presented as means ± SE.
Fig. 3.
Fig. 3.
A: plasma creatinine (Cr in mg/dl) from studies with TGF-β1+/+ and +/− mice. Twenty-four hours after renal ischemia-reperfusion (IR), plasma Cr were measured in sham-operated mice (Sham; n = 4) or mice subjected to IR under pentobarbital sodium anesthesia (PB IR; n = 8 for TGF-β1+/+ mice, n = 9 for TGF-β1+/− mice) or sevoflurane anesthesia (Sevo IR; n = 6 for TGF-β1+/+ mice, n = 6 for TGF-β1+/− mice). Some TGF-β1+/+ mice were injected with TGF-β1 neutralizing antibody and subjected to renal IR under either pentobarbital sodium or sevoflurane anesthesia (n = 4). B: plasma Cr from studies with SMAD3+/+ and −/− mice. Twenty-four hours after renal IR, plasma Cr were measured in Sham (n = 4) or mice subjected to IR under PB IR (n = 5 for SMAD3+/+ and n = 6 for SMAD3−/− mice) or Sevo IR (n = 6 for SMAD3+/+ and n = 4 for SMAD3−/− mice). *P < 0.05 vs. sham-operated +/+ mice. #P < 0.05 vs. +/+ mice subjected to IR under pentobarbital sodium anesthesia. Data presented as means ± SE.
Fig. 4.
Fig. 4.
Representative of 6 photomicrographs (hematoxylin and eosin staining, magnification ×200) from studies with TGF-β1+/+ and +/− mice (A) or SMAD3+/+ and −/− mice (B). Pictures of outer medulla of the kidneys of sham-operated mice and mice subjected to renal IR injury under PB IR or Sevo IR anesthesia 24 h before. C: renal injury scores for the histologic appearance of acute tubular necrosis from sham-operated TGF-β1 mice (Sham) and mice subjected to renal IR during PB IR (n = 6 for TGF-β1+/+ mice, n = 6 for TGF-β1+/− mice) or during Sevo IR (n = 5 for TGF-β1+/+ mice, n = 6 for TGF-β1+/− mice). D: renal injury scores for the histologic appearance of acute tubular necrosis from sham-operated SMAD3 mice (Sham) and mice subjected to renal IR during PB IR (n = 4 for SMAD3+/+ and n = 4 for SMAD3−/− mice) or during Sevo IR (n = 6 for SMAD3+/+ and n = 4 for SMAD3−/− mice). *P < 0.05 vs. sham group. #P < 0.05 vs. +/+ PB IR group. Data are presented as means ± SE. Statistical analysis performed using the Kruskal-Wallis nonparametric test with Dunn posttest comparison.
Fig. 5.
Fig. 5.
A: representative image of EMSA studies for transcription factor NF-κB (top) and SMAD3 (bottom) binding activity in renal proximal tubules from TGF-β1+/+ and +/− mice. Percoll gradient-separated proximal tubules were maintained for 24 h and treated with vehicle (Veh), 10 ng/ml tumor necrosis factor-α (TNF-α), 2.2% sevoflurane (Sevo), or TNF-α plus 2.2% sevoflurane for 16 h. B: densitometric quantifications of relative band intensities from NF-κB (top) and SMAD3 (bottom) EMSA (n = 4). *P < 0.05 vs. vehicle-treated cells from TGF-β1+/+ mice. #P < 0.05 vs. TNF-α-treated cells from TGF-β1+/+ mice. Means ± SE.
Fig. 6.
Fig. 6.
LDH release after vehicle or H2O2 treatment (0–5 mM) for 4 h in proximal tubule cells cultured from TGF-β1+/+ and +/− mice (A) or SMAD3+/+ and −/− mice (B). Cells were treated with H2O2 16 h after treatment with carrier gas (room air plus 5% CO2) or with 2.2% sevoflurane in carrier gas (n = 6). *P < 0.05 vs. LDH released from +/+ mice proximal tubules with H2O2 injury after carrier gas pretreatment.

Similar articles

Cited by

References

    1. Bove T, Calabro MG, Landoni G, Aletti G, Marino G, Crescenzi G, Rosica C, Zangrillo A. The incidence and risk of acute renal failure after cardiac surgery. J Cardiothorac Vasc Anesth 18: 442–445, 2004. - PubMed
    1. Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, Daley J. Preoperative renal risk stratification. Circulation 95: 878–884, 1997. - PubMed
    1. Conlon PJ, Stafford-Smith M, White WD, Newman MF, King S, Winn MP, Landolfo K. Acute renal failure following cardiac surgery. Nephrol Dial Transplant 14: 1158–1162, 1999. - PubMed
    1. Diebold RJ, Eis MJ, Yin M, Ormsby I, Boivin GP, Darrow BJ, Saffitz JE, Doetschman T. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc Natl Acad Sci USA 92: 12215–12219, 1995. - PMC - PubMed
    1. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101: 890–898, 1998. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources

  NODES
twitter 2